Literature DB >> 17546593

Mutations of the PIK3CA gene in hereditary colorectal cancers.

Michiko Miyaki1, Takeru Iijima, Tatsuro Yamaguchi, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Nobuaki Funata, Takeo Mori.   

Abstract

Somatic mutations of the PIK3CA gene have recently been detected in various human cancers, including sporadic colorectal cancer. However, mutations of the PIK3CA gene in hereditary colorectal cancers have not been clarified. To elucidate the mutation status in familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC), which are the most common hereditary colorectal cancers, we investigated PIK3CA mutations in 163 colorectal tumors, including adenomas, intramucosal carcinomas and invasive carcinomas. For comparison, we also analyzed mutations of the same gene in 160 sporadic colorectal tumors at various histopathological stages. Analysis at exons 1, 7, 9 and 20 of the PIK3CA gene revealed somatic mutations in 21% (8 of 39) of FAP invasive carcinomas, 21% (7 of 34) of HNPCC invasive carcinomas, 15% (8 of 52) of sporadic invasive carcinomas, and 14% (7 of 50) of sporadic colorectal metastases in the liver. Mutations in FAP and HNPCC carcinomas predominantly occurred in the kinase domain (exon 20), while the majority of mutations in sporadic cases occurred in the helical domain (exon 9). Adenomas and intramucosal carcinomas from all patients exhibited no mutations (0 of 148). Our data suggest that PIK3CA mutations contribute to the invasion step from intramucosal carcinoma to invasive carcinoma in colorectal carcinogenesis in FAP and HNPCC patients at a similar extent to that seen in sporadic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546593     DOI: 10.1002/ijc.22829

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis.

Authors:  Arantza Fariña Sarasqueta; Eliane C M Zeestraten; Tom van Wezel; Gesina van Lijnschoten; Ronald van Eijk; Jan Willem T Dekker; Peter J K Kuppen; Ines J Goossens-Beumer; Valery E P P Lemmens; Cornelis J H van de Velde; Harm J T Rutten; Hans Morreau; A J C van den Brule
Journal:  Cell Oncol (Dordr)       Date:  2011-08-10       Impact factor: 6.730

3.  PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Kaori Shima; Natsumi Irahara; Shoko Kure; Andrew T Chan; Jeffrey A Engelman; Peter Kraft; Lewis C Cantley; Edward L Giovannucci; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

4.  Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase α that are critical for catalysis and substrate recognition.

Authors:  Sweta Maheshwari; Michelle S Miller; Robert O'Meally; Robert N Cole; L Mario Amzel; Sandra B Gabelli
Journal:  J Biol Chem       Date:  2017-07-04       Impact factor: 5.157

Review 5.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

6.  Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.

Authors:  Anna Isinger Ekstrand; Mats Jönsson; Annika Lindblom; Ake Borg; Mef Nilbert
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

7.  PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

Authors:  Katsuhiko Nosho; Takako Kawasaki; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Dimity Zepf; Liying Yan; Janina A Longtine; Charles S Fuchs; Shuji Ogino
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

8.  Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.

Authors:  Giovanni Corso; Valeria Pascale; Giuseppe Flauti; Francesco Ferrara; Daniele Marrelli; Franco Roviello
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

Review 9.  NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer.

Authors:  Yi Cai; Andrew Yousef; Jennifer R Grandis; Daniel E Johnson
Journal:  Adv Biol Regul       Date:  2019-09-15

10.  PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.

Authors:  Christophe Rosty; Joanne P Young; Michael D Walsh; Mark Clendenning; Kristy Sanderson; Rhiannon J Walters; Susan Parry; Mark A Jenkins; Aung Ko Win; Melissa C Southey; John L Hopper; Graham G Giles; Elizabeth J Williamson; Dallas R English; Daniel D Buchanan
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.